Journal
MICROBIAL DRUG RESISTANCE
Volume 26, Issue 6, Pages 630-636Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/mdr.2019.0276
Keywords
CRISPR-Cas; carbapenem resistant; K; pneumoniae; virulence
Ask authors/readers for more resources
Aim:In this study, we aimed to characterize the CRISPR-Cas systems in clinical carbapenem-resistantKlebsiella pneumoniae(CRKP) isolates and to investigate the potential association of CRISPR-Cas systems with bacterial virulence. Methods:A total of 168 CRKP strains were collected from inpatients in a teaching hospital in Jiangxi Province. Five common carbapenemase genes, subtype genes of the CRISPR-Cas system, and 13 virulence genes were amplified by PCR using specific primers. The potential virulence of all the clinical CRKP strains was tested in aGalleria mellonellainfection model. Results:PCR analysis of five common carbapenemase genes revealed the frequency of carbapenemase geneKPC-2was the highest in the CRISPR-negative strains, compared to CRISPR type I-E* strains or CRISPR type I-E strains (p < 0.01). Isolates having the subtype I-E* CRISPR-Cas system tended to have more virulence genes such asmagA,kfu,wcaG, andallS, compared to CRISPR-negative isolates and type I-E CRISPR-Cas isolates (p < 0.01). The average survival time of the larvae infected with the isolates having the subtype I-E* CRISPR-Cas system was significantly shorter than the other two group isolates (p < 0.05). Conclusion:The CRKP strains, which had the subtype I-E CRISPR-Cas system or the subtype I-E* CRISPR-Cas system, showed reduced acquisition of carbapenemase genes compared to CRISPR-negative isolates. Importantly, we first found that a small portion of CR-hvKP strains were selected from the CRKP clones, which had the type I-E* CRISPR-Cas systems.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available